385 related articles for article (PubMed ID: 15060527)
1. siRNAs: applications in functional genomics and potential as therapeutics.
Dorsett Y; Tuschl T
Nat Rev Drug Discov; 2004 Apr; 3(4):318-29. PubMed ID: 15060527
[No Abstract] [Full Text] [Related]
2. Strategic Research Institute--first international siRNA conference. Prospect for new therapeutics and commercial opportunities for pharma and biotech. 24-25 March 2003, LaJolla, CA, USA.
Xu J
IDrugs; 2003 May; 6(5):449-50. PubMed ID: 12841209
[TBL] [Abstract][Full Text] [Related]
3. Drug Discovery Technology 2003--seventh annual conference and exhibition. Science, business and IT for drug discovery I. 31 March-3 April 2003, Stuttgart, Germany.
Mackonochie M
IDrugs; 2003 May; 6(5):417-9. PubMed ID: 12841199
[No Abstract] [Full Text] [Related]
4. The business of RNAi therapeutics.
Haussecker D
Hum Gene Ther; 2008 May; 19(5):451-62. PubMed ID: 18435603
[No Abstract] [Full Text] [Related]
5. Deal watch: Trends in platform technology deal-making.
Walker J; Jacob J
Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
[No Abstract] [Full Text] [Related]
6. BioChannel 2004. 2 December 2004, Ashford, UK.
Worker C
IDrugs; 2005 Feb; 8(2):115-7. PubMed ID: 15696411
[No Abstract] [Full Text] [Related]
7. Rediscovering plant-based drugs.
Littleton J; Falcone D; Davies HM
Nat Biotechnol; 2003 Aug; 21(8):843-4. PubMed ID: 12894188
[No Abstract] [Full Text] [Related]
8. Decline in economic returns from new drugs raises questions about sustaining innovations.
Berndt ER; Nass D; Kleinrock M; Aitken M
Health Aff (Millwood); 2015 Feb; 34(2):245-52. PubMed ID: 25646104
[TBL] [Abstract][Full Text] [Related]
9. Prescription for an ailing pharmaceutical industry.
Demain AL
Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826
[No Abstract] [Full Text] [Related]
10. Drug Discovery Technology 2003--seventh annual conference and exhibition. Science, business and IT for drug discovery II. 31 March-3 April 2003, Stuttgart, Germany.
Mackonochie M
IDrugs; 2003 May; 6(5):420-2. PubMed ID: 12841200
[No Abstract] [Full Text] [Related]
11. What's fueling the biotech engine?
Aggarwal S
Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
[No Abstract] [Full Text] [Related]
12. Biotechnology partnerships--medicine for an ailing industry?
DeLamarter J
Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
[No Abstract] [Full Text] [Related]
13. Biotechnology and therapeutics: expensive treatments and limited resources. A view from the hospital.
Meyer BR
Clin Pharmacol Ther; 1992 Apr; 51(4):359-65. PubMed ID: 1563205
[No Abstract] [Full Text] [Related]
14. Shining Nordic lights: Swedish science parks drive international biotech research.
Williams Y
Drug Discov Today; 2005 Apr; 10(8):542-4. PubMed ID: 15837596
[No Abstract] [Full Text] [Related]
15. SOZO--a Euro-Japanese biotechnology conference.
Veryard C
IDrugs; 2005 Jul; 8(7):560-2. PubMed ID: 15973563
[No Abstract] [Full Text] [Related]
16. siRNAs in drug discovery: target validation and beyond.
Natt F
Curr Opin Mol Ther; 2007 Jun; 9(3):242-7. PubMed ID: 17608022
[TBL] [Abstract][Full Text] [Related]
17. The evolution of biotech.
Berg C; Nassr R; Pang K
Nat Rev Drug Discov; 2002 Nov; 1(11):845-6. PubMed ID: 12425308
[No Abstract] [Full Text] [Related]
18. The state of innovation in drug development.
Kola I
Clin Pharmacol Ther; 2008 Feb; 83(2):227-30. PubMed ID: 18202690
[TBL] [Abstract][Full Text] [Related]
19. Packaging challenges: the solution is just beyond the border.
Merritt J
Med Device Technol; 2003 Mar; 14(2):12-5. PubMed ID: 12698691
[TBL] [Abstract][Full Text] [Related]
20. The gold rush.
Bryant A
Newsweek; 2000 Apr; 135(15):64-7. PubMed ID: 10847895
[No Abstract] [Full Text] [Related]
[Next] [New Search]
